| MVI (−) | MVI (+) | P |
性别 |
|
| 0.142 |
女 | 5 (10.4%) | 15 (20.5%) |
|
男 | 43 (89.6%) | 58 (79.5%) |
|
年龄 | 60.13 ± 10.74 | 58.51 ± 11.02 | 0.737 |
AFP (ng/ml) | 32.82 (3.01, 874.55) | 268.00 (8.26, 1210) | 0.042 |
肿瘤最大径(mm) | 39.70 (28.30, 88.03) | 62.00 (41.05, 86.55) | 0.048 |
肿瘤包膜 |
|
| 0.825 |
无 | 24 (50%) | 35 (47.9%) |
|
有 | 24 (50%) | 38 (52.1%) |
|
肿瘤形态 |
|
| 0.001 |
规则 | 21 (43.8%) | 12 (16.4%) |
|
不规则 | 27 (56.2%) | 61 (83.6%) |
|
瘤周低密度环征 |
|
| 0.895 |
无 | 31 (64.6%) | 48 (65.8%) |
|
有 | 17 (35.4%) | 25 (34.2%) |
|
瘤内动脉 |
|
| 0.043 |
无 | 21 (43.8%) | 19 (26.0%) |
|
有 | 27 (56.2%) | 54 (74.0%) |
|
病灶数目 |
|
| 0.006 |
单发 | 37 (77.1%) | 38 (52.1%) |
|
多发 | 11 (22.9%) | 35 (47.9%) |
|
瘤周异常灌注 |
|
| 0.148 |
无 | 32 (66.7%) | 39 (53.4%) |
|
有 | 16 (33.3%) | 34 (46.6%) |
|
大血管侵犯 |
|
| 0.024 |
无 | 42 (87.5%) | 51 (69.9%) |
|
有 | 6 (12.5%) | 22 (30.1%) |
|
强化方式 |
|
| 0.694 |
典型 | 36 (75.0%) | 57 (78.1%) |
|
不典型 | 12 (25.0%) | 16 (21.9%) |
|